94 related articles for article (PubMed ID: 15544851)
1. Tubular albumin uptake: is there evidence for a quantitatively important, receptor-independent mechanism?
Birn H; Nielsen R; Weyer K
Kidney Int; 2023 Dec; 104(6):1069-1073. PubMed ID: 37981430
[No Abstract] [Full Text] [Related]
2. Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?
Choi MR; Fernández BE
Front Physiol; 2021; 12():680213. PubMed ID: 34135773
[TBL] [Abstract][Full Text] [Related]
3. Acute infusion of angiotensin II regulates organic cation transporters function in the kidney: its impact on the renal dopaminergic system and sodium excretion.
Kouyoumdzian NM; Rukavina Mikusic NL; Robbesaul GD; Gorzalczany SB; Carranza A; Trida V; Fernández BE; Choi MR
Hypertens Res; 2021 Mar; 44(3):286-298. PubMed ID: 32934369
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney.
Rukavina Mikusic NL; Kouyoumdzian NM; Rouvier E; Gironacci MM; Toblli JE; Fernández BE; Choi MR
Scientifica (Cairo); 2016; 2016():6302376. PubMed ID: 27635280
[TBL] [Abstract][Full Text] [Related]
5. Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium Excretion.
Kouyoumdzian NM; Rukavina Mikusic NL; Kravetz MC; Lee BM; Carranza A; Del Mauro JS; Pandolfo M; Gironacci MM; Gorzalczany S; Toblli JE; Fernández BE; Choi MR
PLoS One; 2016; 11(7):e0157487. PubMed ID: 27392042
[TBL] [Abstract][Full Text] [Related]
6. Renal dopaminergic system: Pathophysiological implications and clinical perspectives.
Choi MR; Kouyoumdzian NM; Rukavina Mikusic NL; Kravetz MC; Rosón MI; Rodríguez Fermepin M; Fernández BE
World J Nephrol; 2015 May; 4(2):196-212. PubMed ID: 25949933
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system.
Rukavina Mikusic NL; Kravetz MC; Kouyoumdzian NM; Della Penna SL; Rosón MI; Fernández BE; Choi MR
J Signal Transduct; 2014; 2014():731350. PubMed ID: 25436148
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide and renal dopaminergic system: a positive friendly relationship?
Choi MR; Rukavina Mikusic NL; Kouyoumdzian NM; Kravetz MC; Fernández BE
Biomed Res Int; 2014; 2014():710781. PubMed ID: 25013796
[TBL] [Abstract][Full Text] [Related]
9. Role of atrial natriuretic peptide in mediating the blood pressure-independent natriuresis elicited by systemic inhibition of nitric oxide.
Dobrowolski L; Kuczeriszka M; Castillo A; Majid DS; Navar LG
Pflugers Arch; 2015 Apr; 467(4):833-41. PubMed ID: 24953240
[TBL] [Abstract][Full Text] [Related]
10. Urodilatin increases renal dopamine uptake: intracellular network involved.
Choi MR; Citarella MR; Lee BM; Lucano F; Fernández BE
J Physiol Biochem; 2011 Jun; 67(2):243-7. PubMed ID: 21210317
[TBL] [Abstract][Full Text] [Related]
11. Urodilatin and dopamine: a new interaction in the kidney.
Citarella MR; Choi MR; Gironacci MM; Medici C; Correa AH; Fernández BE
Regul Pept; 2009 Feb; 153(1-3):19-24. PubMed ID: 19101594
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of release and renal tubular action of atrial natriuretic factor.
Sonnenberg H
Fed Proc; 1986 Jun; 45(7):2106-10. PubMed ID: 3011520
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic factor stimulates renal dopamine uptake mediated by natriuretic peptide-type A receptor.
Fernández BE; Correa AH; Choi MR
Regul Pept; 2005 Jan; 124(1-3):137-44. PubMed ID: 15544851
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic factor decreases renal dopamine turnover and catabolism without modifying its release.
Correa AH; Choi MR; Gironacci M; Aprile F; Fernández BE
Regul Pept; 2008 Feb; 146(1-3):238-42. PubMed ID: 17963868
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
